Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...

Rochester, Minnesota—Left ventricular dysfunction is the medical name for a weak heart pump. It's a condition that impacts about 9% of people over the age of 60. Paul Friedman, M.D., a cardiologist at ...

Declines in physical function from androgen deprivation therapy (ADT) in men with nonmetastatic prostate cancer: A matched cohort study No significant financial relationships to disclose. This is an ...

The first randomized trial to compare standard percutaneous coronary intervention (PCI), also known as coronary angioplasty, with PCI accompanied by the use of a temporary, miniaturized pump to ...

Please provide your email address to receive an email when new articles are posted on . Subclinical left ventricular abnormalities in SSc impact survival and increase dyspnea risk. LV ejection ...

For stabilized AMI without left ventricular systolic dysfunction or HF, discontinuing β-blockers after 1 year or longer is noninferior to continuing it.

Cardiotoxicity is a well-established complication of multiple cancer therapeutics, and the one of the most prominent effects that limits the use of these agents is in the form of left ventricular ...

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease ...

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...